drugset / Trial / NCT04527900

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

NCT04527900 ↗

Phase 2 Terminated 2 enrolled University of Maryland, Baltimore
NaSingle-groupOpen-labelTreatment

Summary

A phase 2 study with the primary objective of testing treatment compliance of Upfront Intensity Modulated Proton Beam Therapy (IMPT) and Concurrent Chemotherapy (UPPROACH) for Post-operative Treatment in Loco-regionally Advanced Endometrial Cancer is non-inferior to the historic compliance rate of the chemoradiation arm of GOG 258 study

Timeline

Start
2021-02-23
Primary completion
2024-07-02
Completion
2024-07-02

Outcome

Outcome not reported

Stopped (Enrollment): “SOC changed and low enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — —
Subject Paclitaxel Small molecule — —

Indications